Cover Image

Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real‐world multicenter cohort study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Hyunjae Shin, Seung Up Kim, Byeong Geun Song, Youngsu Park, Yunmi Ko, Jeayeon Park, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Jung‐Hwan Yoon, Dong Hyun Sinn, Yoon Jun Kim
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Hepatology Research
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA
by: Shunsuke Yamada, et al.
Published: (2024)

Correction to “Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA”
Published: (2025)

Kinetics of the hepatitis B core‐related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamide
by: Norio Itokawa, et al.
Published: (2024)

Letter: Risk Prediction Model for HCC in Subjects Without Apparent Chronic Liver Disease: A Dilemma in Asia. Author's Reply
by: Byeong Geun Song, et al.
Published: (2025)

Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance
by: Han Ah. Lee, et al.
Published: (2025)

Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes
by: Huey‐Ling Chen, et al.
Published: (2024)

Diagnostic Value of MR Elastography and MRI‐Proton Density Fat Fraction in Cirrhosis Based on Explant Liver Histology
by: Eun‐Ki Min, et al.
Published: (2026)

Incidence of metabolic dysfunction‐associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study
by: Kunhee Kim, et al.
Published: (2024)

No observed bidirectional effect between tenofovir diphosphate concentrations and gender‐affirming hormone concentrations among transgender persons switching from tenofovir disoproxil fumarate/emtricitabine to tenofovir alafenamide/emtricitabine for HIV pre‐exposure prophylaxis
by: Nimish Patel, et al.
Published: (2024)

The Impact of Liraglutide on Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
by: Jae Eun So, et al.
Published: (2025)

Metabolic effects of switching to Biktarvy (B/F/TAF) in patients with HIV‐1 treated with antiretroviral regimens that do not include tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF): The Metabic study
by: C. Busca‐Arenzana, et al.
Published: (2024)

Long‐Term Surveillance for Pancreatic Carcinoma Among Patients With Branch‐Duct Intraductal Papillary Mucinous Neoplasms
by: Gaeun Lee, et al.
Published: (2025)

Efficacy and safety of tegoprazan‐ and rabeprazole‐based concomitant therapies for Helicobacter pylori infection: Real‐world evidence
by: Byung Wook Jung, et al.
Published: (2024)

Comparative efficacy of Helicobacter pylori eradication therapy between tegoprazan‐based concomitant and bismuth quadruple therapies: A real‐world evidence
by: Yoon Suk Jung, et al.
Published: (2024)

Comparative Validation of Prediction Models for HCC Outcomes in Living Donor Liver Transplantation: Superiority of Tumor Markers to Imaging Study
by: Hwa‐Hee Koh, et al.
Published: (2024)

Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma
by: Seung Kak Shin, et al.
Published: (2024)

Nonlesional ileal transcriptome in Crohn's disease reveals alterations in immune response and metabolic pathway
by: Ho‐Su Lee, et al.
Published: (2024)

New nomenclature and subclassification of steatotic liver disease and loss of skeletal muscle mass: A longitudinal cohort study
by: Aryoung Kim, et al.
Published: (2024)

Second Examination of the Right Colon Using Narrow‐Band Imaging Increases Adenoma Detection Rates in the Right Colon: A Multicenter, Randomized Controlled Trial
by: Shin Hee Kim, et al.
Published: (2025)

Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma
by: Jungnam Lee, et al.
Published: (2024)

Macrophage Histone Deacetylase 4 Has Sex‐Dependent Dimorphic Effects on the Pathogenesis of Alcohol‐Associated Hepatitis
by: Hyunju Kang, et al.
Published: (2025)

Neutrophil‐to‐lymphocyte ratio at the start of the second course of durvalumab plus tremelimumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis
by: Takanori Suzuki, et al.
Published: (2025)

Synthesis and characterization of tenofovir disoproxil fumarate loaded nanoparticles for HIV‐1 treatment
by: Oluwafemi Samuel Obisesan, et al.
Published: (2024)

Optimal treatment strategy and prognostic analysis of salvage liver transplantation for patients with early hepatocellular carcinoma recurrence after hepatectomy
by: Hao‐Chien Hung, et al.
Published: (2024)

The Predictive Value of Time‐Varying Noninvasive Scores on Long‐Term Prognosis of NAFLD in South Korea
by: Sung Won Chung, et al.
Published: (2024)

Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child–Pugh A category: A multicenter study
by: Ying Zhang, et al.
Published: (2024)

Association of proteinuria with improved prognosis in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab, and the predictive role of serum vascular endothelial growth factor D levels: A multicenter retrospective study
by: Zijian Yang, et al.
Published: (2024)

Automatic assessment of bowel preparation by an artificial intelligence model and its clinical applicability
by: Ji Young Lee, et al.
Published: (2024)

Chronic Kidney Disease Risk Associated With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Nationwide Cohort Study in Korea
by: Dong Wook Kim, et al.
Published: (2025)

Limited use of FIB‐4 index in patients under 65 years of age with type 2 diabetes mellitus
by: Mimi Kim, et al.
Published: (2024)

Systemic Therapy for Advanced Biliary Tract Cancers in 2026: Current Standard of Care and Emerging Therapeutic Strategies
by: Hyunseok Yoon, et al.
Published: (2025)

Clinical Factors Associated With Endoscopic Decompression Failure and Recurrent Sigmoid Volvulus: A Retrospective Cohort Study
by: Seoyoon Choi, et al.
Published: (2026)

MRI for hepatocellular carcinoma and the role of abbreviated MRI for surveillance of hepatocellular carcinoma
by: Soe Thiha Maung, et al.
Published: (2024)

Head‐to‐Head Comparison of Long‐Term HCC Risk of Antivirals‐Treated Versus Untreated Low‐Level Viremia in HBV‐Compensated Cirrhosis
by: Nobuharu Tamaki, et al.
Published: (2025)

A classification model for resectability in hepatocellular carcinoma patients
by: Ikuo Nakamura, et al.
Published: (2024)

Utility of Peroral Cholangioscopy in the Diagnosis and Management of Intraductal Papillary Neoplasms of the Bile Duct (With Videos)
by: Il Sang Shin, et al.
Published: (2025)

Efficacy of Biliary Brush Cytology With Rapid On‐Site Cytological Evaluation for the Detection of Malignant Biliary Strictures
by: Il Sang Shin, et al.
Published: (2025)

Immunometabolic Signatures in Chronic DILI: An Integrated and Translational Perspective
by: Semin Lee, et al.
Published: (2025)

The association between proton‐pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy
by: Chun‐Ting Ho, et al.
Published: (2024)

Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C
by: Yu Rim Lee, et al.
Published: (2025)